Business
Real-World Deployments Signal AI Healthcare Is Ready for Scale
Real-World Deployments Signal AI Healthcare Is Ready for Scale Canada NewsWire ...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"\n\n\n\n Real-World Deployments Signal AI Healthcare Is Ready for Scale\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n Equity Insider\n \n\n\n News Commentary\n \n\n\n\n\n Issued on behalf of Avant Technologies Inc.\n \n\n\n\n\n\n VANCOUVER, BC\n \n\n ,\n \n\n May 30, 2025\n \n\n /CNW/ -- The concept of AI in healthcare is no longer a novelty,\n \n experts are acknowledging\n \n AI algorithms, detection, and drug discovery are becoming indispensable tools. As medical errors continue to harm patients, healthcare experts are turning to AI to\n \n improve mistakes in medications\n \n , such as prescribing the wrong drug or wrong dose. As real-world deployment\n \n gains momentum\n \n , a number of tech and biotech firms are already translating AI healthcare innovation into clinical practice. Notable recent activity includes initiatives from\n \n Avant Technologies, Inc.\n \n (OTCQB: AVAI),\n \n Tempus AI, Inc.\n \n (NASDAQ: TEM),\n \n BioXcel Therapeutics, Inc.\n \n (NASDAQ: BTAI),\n \n Healwell AI Inc.\n \n (TSX: AIDX) (OTCPK: HWAIF), and\n \n WELL Health Technologies Corp.\n \n (TSX: WELL) (OTCQX: WHTCF).\n \n\n\n\n\n\n\n\n\n\n Cathie Wood\n \n\n of\n \n Ark Invest\n \n\n recently highlighted\n \n new research from\n \n Mass General Brigham\n \n , where AI models were able to predict cancer survival outcomes based on facial images—an example she cited as evidence that healthcare could become\n \n AI's most transformative use case\n \n . Industry forecasts support that trajectory, with\n \n Statista\n \n\n estimating\n \n that the global AI healthcare market will grow from roughly\n \n $11 billion\n \n today to\n \n $188 billion\n \n by 2030, reflecting a compound annual growth rate of 37%.\n \n\n\n Avant Technologies, Inc.\n \n (OTCQB: AVAI), in collaboration with\n \n Ainnova Tech\n \n , is quietly building a foothold in the emerging field of predictive diagnostics. Its Vision AI platform is designed to identify disease markers at the earliest possible stage—sometimes before outward symptoms emerge—by leveraging ...